Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.
Follow-Up Questions
Institute of Biomedical Research Corp의 CEO는 누구입니까?
Boris Olekhnovich은 2011부터 회사에 합류한 Institute of Biomedical Research Corp의 President입니다.
MRES 주식의 가격 성능은 어떻습니까?
MRES의 현재 가격은 $0.006이며, 전 거래일에 decreased 0% 하였습니다.
Institute of Biomedical Research Corp의 주요 사업 주제나 업종은 무엇입니까?
Institute of Biomedical Research Corp은 N/A 업종에 속하며, 해당 부문은 N/A입니다
Institute of Biomedical Research Corp의 시가총액은 얼마입니까?
Institute of Biomedical Research Corp의 현재 시가총액은 $14.3M입니다
